Market Cap 709.90M
Revenue (ttm) 0.00
Net Income (ttm) -108.68M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.22
Volume 900,100
Avg Vol 1,195,294
Day's Range N/A - N/A
Shares Out 76.09M
Stochastic %K 76%
Beta 2.48
Analysts Strong Sell
Price Target $25.00

Company Profile

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is head...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 220 6633
Address:
One World Trade Center, Suite 8500, New York, United States
loris16148
loris16148 Sep. 12 at 1:53 AM
$MNMD latest green candle enveloping more than half of the previous red candle. Likely a positive sign. 9.80 tomorrow
0 · Reply
twiggs462
twiggs462 Sep. 12 at 1:19 AM
$MNMD MM120 Effective as a Single Dose for Generalized Anxiety Disorder: Phase 2b Results | HCP Live Investigator Maurizio Fava, MD, chair of Mass General Brigham, discusses how MindMed’s MM120 (lysergide D-tartrate, LSD) at 100 μg signficantly reduces anxiety in adults with generalized anxiety disorder (GAD). https://www.hcplive.com/shorts/mm120-effective-as-single-dose-generalized-anxiety-disorder-phase-2b-results Mass General was one of the first providers in the US who offered IV ketamine for depressed people. I predict that will be one of the first adopters of this treatment as well
0 · Reply
a_rational_investor
a_rational_investor Sep. 11 at 9:20 PM
$MNMD I find it so funny how the stock always tanks after hours and then immediately gets right back to the same level 5-10 min later
0 · Reply
CuriousChimps
CuriousChimps Sep. 11 at 7:12 PM
$MNMD can’t stop this beast
0 · Reply
PsychedStocks
PsychedStocks Sep. 11 at 2:02 PM
$CYBN $CMPS $ATAI $MNMD $SPY Cybin to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit https://ir.cybin.com/investors/news/news-details/2025/Cybin-to-Participate-in-TD-Cowens-5th-Annual-Novel-Mechanisms-in-Neuropsychiatry--Epilepsy-Summit/default.aspx
1 · Reply
brunoq14
brunoq14 Sep. 11 at 11:40 AM
$MNMD Phase 3 result in GAD coming up here in H1 2026, another GAD and an MDD in H2. Going after two major indications with the same drug.
1 · Reply
AustrianAssassin
AustrianAssassin Sep. 10 at 5:14 PM
$MNMD it always drops once it approaches 10$. 8.50 is the lows, $10 is the high as far as range. Gonna need a catalyst to jump over $10 for good
0 · Reply
loris16148
loris16148 Sep. 10 at 4:46 PM
$MNMD consolidating after touching 9.90s.
0 · Reply
GoldenBull13
GoldenBull13 Sep. 10 at 1:53 PM
$MNMD Daily MACD flipping green and RSI breakout. Ready to break past the $10 resistance.
0 · Reply
Quantumup
Quantumup Sep. 10 at 12:24 PM
Cantor Fitzgerald reiterated $GHRS Overweight/$25: $ATAI $JNJ $CMPS CYBN $MNMD A repeating theme we've heard in all of our webinars: Psychiatry is on the verge of delivering transformational value for millions of people in the U.S. (and millions more ex-U.S.) struggling with mental health conditions. Spravato is warming up the interventional psychiatry field. Of the 6000+ Spravato clinics, around half have gone online in the last 6 mos. Spravato is allowing clinics to understand the buy and bill system of the next wave of interventional therapies, as well as help iron out the CPT codes for reimbursement of healthcare practitioner time. Hospitals are interested in psychedelics too, not just interventional psychiatry clinics. Many have more capacity than people realize - with electroconvulsive therapy (ECT) falling out of favor, hospitals are exploring transitioning these rooms to psychedelic delivery suites.
1 · Reply
Latest News on MNMD
MindMed Announces New Employee Inducement Grants

Sep 8, 2025, 4:01 PM EDT - 3 days ago

MindMed Announces New Employee Inducement Grants


MindMed to Participate in September Investor Conferences

Aug 28, 2025, 7:00 AM EDT - 14 days ago

MindMed to Participate in September Investor Conferences


MindMed Reports Q2 2025 Financial Results and Business Updates

Jul 31, 2025, 4:01 PM EDT - 6 weeks ago

MindMed Reports Q2 2025 Financial Results and Business Updates


MindMed to Participate in June Investor Conferences

May 28, 2025, 7:00 AM EDT - 3 months ago

MindMed to Participate in June Investor Conferences


MindMed Appoints Matt Wiley as Chief Commercial Officer

Mar 17, 2025, 7:00 AM EDT - 6 months ago

MindMed Appoints Matt Wiley as Chief Commercial Officer


MindMed to Be Added to the Nasdaq Biotechnology Index

Dec 19, 2024, 7:00 AM EST - 9 months ago

MindMed to Be Added to the Nasdaq Biotechnology Index


MindMed to Participate in Upcoming Investor Conferences

Nov 13, 2024, 7:00 AM EST - 10 months ago

MindMed to Participate in Upcoming Investor Conferences


Mind Medicine: No News = Good News

Nov 10, 2024, 9:55 AM EST - 10 months ago

Mind Medicine: No News = Good News


Psychedelic Stocks: Focus On Their Cash

Aug 15, 2024, 12:30 PM EDT - 1 year ago

Psychedelic Stocks: Focus On Their Cash

CMPS


Pacific Defense Announces US Army CMFF Program Team

Aug 13, 2024, 7:01 AM EDT - 1 year ago

Pacific Defense Announces US Army CMFF Program Team

MRNS


loris16148
loris16148 Sep. 12 at 1:53 AM
$MNMD latest green candle enveloping more than half of the previous red candle. Likely a positive sign. 9.80 tomorrow
0 · Reply
twiggs462
twiggs462 Sep. 12 at 1:19 AM
$MNMD MM120 Effective as a Single Dose for Generalized Anxiety Disorder: Phase 2b Results | HCP Live Investigator Maurizio Fava, MD, chair of Mass General Brigham, discusses how MindMed’s MM120 (lysergide D-tartrate, LSD) at 100 μg signficantly reduces anxiety in adults with generalized anxiety disorder (GAD). https://www.hcplive.com/shorts/mm120-effective-as-single-dose-generalized-anxiety-disorder-phase-2b-results Mass General was one of the first providers in the US who offered IV ketamine for depressed people. I predict that will be one of the first adopters of this treatment as well
0 · Reply
a_rational_investor
a_rational_investor Sep. 11 at 9:20 PM
$MNMD I find it so funny how the stock always tanks after hours and then immediately gets right back to the same level 5-10 min later
0 · Reply
CuriousChimps
CuriousChimps Sep. 11 at 7:12 PM
$MNMD can’t stop this beast
0 · Reply
PsychedStocks
PsychedStocks Sep. 11 at 2:02 PM
$CYBN $CMPS $ATAI $MNMD $SPY Cybin to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit https://ir.cybin.com/investors/news/news-details/2025/Cybin-to-Participate-in-TD-Cowens-5th-Annual-Novel-Mechanisms-in-Neuropsychiatry--Epilepsy-Summit/default.aspx
1 · Reply
brunoq14
brunoq14 Sep. 11 at 11:40 AM
$MNMD Phase 3 result in GAD coming up here in H1 2026, another GAD and an MDD in H2. Going after two major indications with the same drug.
1 · Reply
AustrianAssassin
AustrianAssassin Sep. 10 at 5:14 PM
$MNMD it always drops once it approaches 10$. 8.50 is the lows, $10 is the high as far as range. Gonna need a catalyst to jump over $10 for good
0 · Reply
loris16148
loris16148 Sep. 10 at 4:46 PM
$MNMD consolidating after touching 9.90s.
0 · Reply
GoldenBull13
GoldenBull13 Sep. 10 at 1:53 PM
$MNMD Daily MACD flipping green and RSI breakout. Ready to break past the $10 resistance.
0 · Reply
Quantumup
Quantumup Sep. 10 at 12:24 PM
Cantor Fitzgerald reiterated $GHRS Overweight/$25: $ATAI $JNJ $CMPS CYBN $MNMD A repeating theme we've heard in all of our webinars: Psychiatry is on the verge of delivering transformational value for millions of people in the U.S. (and millions more ex-U.S.) struggling with mental health conditions. Spravato is warming up the interventional psychiatry field. Of the 6000+ Spravato clinics, around half have gone online in the last 6 mos. Spravato is allowing clinics to understand the buy and bill system of the next wave of interventional therapies, as well as help iron out the CPT codes for reimbursement of healthcare practitioner time. Hospitals are interested in psychedelics too, not just interventional psychiatry clinics. Many have more capacity than people realize - with electroconvulsive therapy (ECT) falling out of favor, hospitals are exploring transitioning these rooms to psychedelic delivery suites.
1 · Reply
twiggs462
twiggs462 Sep. 10 at 1:58 AM
$MNMD H.C. Wainwright 27th Annual Global Investment Conference https://journey.ct.events/view/c1a22c93-1c8f-46ff-9ce2-c47ba55fb424
0 · Reply
Danyzinho29
Danyzinho29 Sep. 9 at 8:31 PM
$MNMD is participating in several investor conferences in September 2025, including the Cantor Global Healthcare Conference, H.C. Wainwright Annual Global Investment Conference, Baird Global Healthcare Conference, and TD Cowen’s Neuropsychiatry & Epilepsy Summit (source: TipRanks)
0 · Reply
Danyzinho29
Danyzinho29 Sep. 9 at 8:23 PM
$MNMD’s MM120 shows promise in treating Generalized Anxiety Disorder (GAD) https://www.reddit.com/r/MindMedInvestorsClub/s/q6NFTSiiDF
0 · Reply
a_rational_investor
a_rational_investor Sep. 9 at 7:56 PM
$MNMD Back in April we were in the fives pushing for six. Let's keep it up long term. Would love to test past all time highs in a couple years
0 · Reply
loris16148
loris16148 Sep. 9 at 7:10 PM
$MNMD this is good price action. I was expecting 9.50 today but not 9.70. I think will consolidate around this price and then retest 10 again. But with all the good news and tailwind may break through the 10 very soon.
1 · Reply
DCRMIA
DCRMIA Sep. 9 at 6:57 PM
$MNMD are you reeaadyy?? To the moon🚀🌙 $XBI
1 · Reply
a_rational_investor
a_rational_investor Sep. 9 at 6:55 PM
$MNMD huge day!
0 · Reply
CuriousChimps
CuriousChimps Sep. 9 at 2:57 PM
$MNMD something big is about to happen to the sector… I have a feeling
2 · Reply
TheJenkins
TheJenkins Sep. 8 at 9:57 PM
$MNMD can we please push above $10 and get some traction.
2 · Reply
Arnie52
Arnie52 Sep. 8 at 8:42 PM
$MNMD https://www.foxnews.com/health/psychedelic-drug-popular-1960s-could-ease-anxiety-doctors-share-warnings
0 · Reply
CuriousChimps
CuriousChimps Sep. 8 at 8:33 PM
0 · Reply
BobbyCucumber
BobbyCucumber Sep. 8 at 7:30 PM
0 · Reply